Predictions
B2gold Corp.
Start price
Target price
Perf. (%)
€4.06
27.01.20
27.01.20
€20.00
22.02.20
22.02.20
9.95%
22.02.20
22.02.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Austria Microsystems AG
Start price
Target price
Perf. (%)
€37.53
27.01.20
27.01.20
€50.00
08.02.20
08.02.20
11.43%
08.02.20
08.02.20
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Kinross Gold Corp.
Start price
Target price
Perf. (%)
€4.44
27.01.20
27.01.20
-
08.02.20
08.02.20
1.14%
08.02.20
08.02.20
Could be worthwhile Investment >10% per year
Polaris Industries Inc.
Start price
Target price
Perf. (%)
€82.50
26.01.20
26.01.20
€138.00
27.02.20
27.02.20
-8.48%
27.02.20
27.02.20
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€59.00
26.01.20
26.01.20
€45.00
07.02.20
07.02.20
-5.93%
07.02.20
07.02.20
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€35.70
26.01.20
26.01.20
€52.00
04.11.21
04.11.21
-51.51%
05.11.21
05.11.21
Amarin Corp. ADR
Start price
Target price
Perf. (%)
€18.50
26.01.20
26.01.20
€15.00
04.11.21
04.11.21
-79.95%
05.11.21
05.11.21
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.73
26.01.20
26.01.20
-
04.11.21
04.11.21
79.06%
05.11.21
05.11.21
Beyond Meat Inc
Start price
Target price
Perf. (%)
€107.80
25.01.20
25.01.20
-
08.02.20
08.02.20
-1.21%
08.02.20
08.02.20
Revenue growth >5% per year expected
Fannie Mae (Federal National Mortgage Association)
Start price
Target price
Perf. (%)
€2.98
25.01.20
25.01.20
€5.00
09.02.20
09.02.20
6.21%
09.02.20
09.02.20
EBIT growth > 30% per year expected
Very differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Standard Investments for future growth